Your browser doesn't support javascript.
loading
Construction of gastric cancer patient-derived organoids and their utilization in a comparative study of clinically used paclitaxel nanoformulations.
Zou, Jiale; Wang, Shuang; Chai, Ningli; Yue, Hua; Ye, Peng; Guo, Peilin; Li, Feng; Wei, Bo; Ma, Guanghui; Wei, Wei; Linghu, Enqiang.
Affiliation
  • Zou J; Department of Gastroenterology and Hepatology, The First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.
  • Wang S; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, People's Republic of China.
  • Chai N; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, People's Republic of China.
  • Yue H; Department of Gastroenterology and Hepatology, The First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.
  • Ye P; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, People's Republic of China.
  • Guo P; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, People's Republic of China.
  • Li F; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, People's Republic of China.
  • Wei B; School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing, 100049, People's Republic of China.
  • Ma G; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, People's Republic of China.
  • Wei W; School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing, 100049, People's Republic of China.
  • Linghu E; Department of General Surgery, The First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.
J Nanobiotechnology ; 20(1): 233, 2022 May 18.
Article in En | MEDLINE | ID: mdl-35585597

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Nanobiotechnology Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Nanobiotechnology Year: 2022 Type: Article